Hemosiderosis laboratory findings

Hemosiderosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hemosiderosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hemosiderosis laboratory findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hemosiderosis laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hemosiderosis laboratory findings
CDC on Hemosiderosis laboratory findings
Hemosiderosis laboratory findings in the news
Blogs on Hemosiderosis laboratory findings
Directions to Hospitals Treating Hemosiderosis
Risk calculators and risk factors for Hemosiderosis laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

The laboratory findings consistent with IPH include reduced hemoglobin counts and hematocrit, leucocytosis, and elevated erythrocyte sedimentation rate.

Laboratory findings

Laboratory findings consistent with the diagnosis of IPH include:

• Reduced hemoglobin counts and hematocrit
• leucocytosis
• Elevated erythrocyte sedimentation rate